» Articles » PMID: 39267923

The Uniqueness of ABCB5 As a Full Transporter ABCB5FL and a Half-transporter-like ABCB5β

Overview
Date 2024 Sep 13
PMID 39267923
Authors
Affiliations
Soon will be listed here.
Abstract

The gene encodes several isoforms, including two transporters (i.e., ABCB5FL, ABCB5β) and several soluble proteins, such as ABCB5α which has been hypothesized to have a regulatory function. ABCB5FL is a full ABC transporter and is expressed in the testis and prostate, whereas ABCB5β is an atypical half-transporter with a ubiquitous expression pattern. ABCB5β has been shown to mark cancer stem cells in several cancer types. In addition, ABCB5β and ABCB5FL have been shown to play a role in tumorigenesis and multidrug resistance. However, ABCB5β shares its entire protein sequence with ABCB5FL, making them difficult to distinguish. It cannot be excluded that some biological effects described for one transporter may be mediated by the other isoform. Therefore, it is difficult to interpret the available data and some controversies remain regarding their function in cancer cells. In this review, we discuss the data collected on ABCB5 isoforms over the last 20 years and propose a common ground on which we can build further to unravel the pathophysiological roles of ABCB5 transporters.

References
1.
Stockwin L . Alveolar soft-part sarcoma (ASPS) resembles a mesenchymal stromal progenitor: evidence from meta-analysis of transcriptomic data. PeerJ. 2020; 8:e9394. PMC: 7307565. DOI: 10.7717/peerj.9394. View

2.
El-Khattouti A, Sheehan N, Monico J, Drummond H, Haikel Y, Brodell R . CD133⁺ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment. Cancer Lett. 2014; 357(1):83-104. DOI: 10.1016/j.canlet.2014.10.043. View

3.
Quintana E, Shackleton M, Foster H, Fullen D, Sabel M, Johnson T . Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell. 2010; 18(5):510-23. PMC: 3031091. DOI: 10.1016/j.ccr.2010.10.012. View

4.
Nair R, Balla M, Khan I, Kalathur R, Kondaiah P, Vemuganti G . In vitro characterization of CD133 cancer stem cells in Retinoblastoma Y79 cell line. BMC Cancer. 2017; 17(1):779. PMC: 5698942. DOI: 10.1186/s12885-017-3750-2. View

5.
McCaffrey T, St Laurent 3rd G, Shtokalo D, Antonets D, Vyatkin Y, Jones D . Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts. BMC Med Genomics. 2020; 13(1):160. PMC: 7594430. DOI: 10.1186/s12920-020-00808-8. View